AAAAAA

   
Results: 1-9 |
Results: 9
Targeting of human Tmolt(4) leukemic type IIIMP dehydrogenase by cyclic imide related derivatives
Authors: Hall, IH Barnes, BJ Ward, ES Wheaton, JR Shaffer, KA Cho, SE Warren, AE
Citation: Ih. Hall et al., Targeting of human Tmolt(4) leukemic type IIIMP dehydrogenase by cyclic imide related derivatives, ARCH PHARM, 334(7), 2001, pp. 229-234
Tmolt(4) leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones
Authors: Hall, IH Barnes, BJ Ward, ES Wheaton, JR Warren, AE Izydore, RA
Citation: Ih. Hall et al., Tmolt(4) leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones, ARCH PHARM, 334(4), 2001, pp. 109-116
The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cells
Authors: Izydore, RA Zhang, Y Zhou, XM Warren, AE Wheaton, JR Hall, IH
Citation: Ra. Izydore et al., The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cells, ANTICANC R, 21(1A), 2001, pp. 157-165
Synthesis and cytotoxicity of 2,4-disubstituted and 2,3,4-trisubstituted brominated pyrroles in murine and human cultured tumor cells
Authors: Gupton, JT Burham, BS Krumpe, K Du, K Sikorski, JA Warren, AE Barnes, CR Hall, IH
Citation: Jt. Gupton et al., Synthesis and cytotoxicity of 2,4-disubstituted and 2,3,4-trisubstituted brominated pyrroles in murine and human cultured tumor cells, ARCH PHARM, 333(1), 2000, pp. 3-9
Cytotoxicity of cobalt complexes of furan oximes in murine and human tissue-cultured cell lines
Authors: Hall, IH Bastow, KF Warren, AE Barnes, CR Bouet, GM
Citation: Ih. Hall et al., Cytotoxicity of cobalt complexes of furan oximes in murine and human tissue-cultured cell lines, APPL ORGAN, 13(11), 1999, pp. 819-828
Cytotoxicity and mode of action of aliphatic dicarboxylic acids in L1210 lymphocytic leukemia cells
Authors: Hall, IH Izydore, RA Warren, AE Barnes, CR
Citation: Ih. Hall et al., Cytotoxicity and mode of action of aliphatic dicarboxylic acids in L1210 lymphocytic leukemia cells, ANTICANC R, 19(1A), 1999, pp. 205-211
The cytotoxicity and mode of action of 2,3,4-trisubstituted pyrroles and related derivatives in human Tmolt(4) leukemia cells
Authors: Gupton, JT Burham, BS Byrd, BD Krumpe, KE Stokes, C Shuford, J Winkle, S Webb, T Warren, AE Barnes, CR Henry, J Hall, IH
Citation: Jt. Gupton et al., The cytotoxicity and mode of action of 2,3,4-trisubstituted pyrroles and related derivatives in human Tmolt(4) leukemia cells, PHARMAZIE, 54(9), 1999, pp. 691-697
Hepatic vein to the azygous vein anastomosis for pulmonary arteriovenous fistulae
Authors: Baskett, RJF Ross, DB Warren, AE Sharratt, GP Murphy, DA
Citation: Rjf. Baskett et al., Hepatic vein to the azygous vein anastomosis for pulmonary arteriovenous fistulae, ANN THORAC, 68(1), 1999, pp. 232-233
Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cells
Authors: Burnham, BS Gupton, JT Krumpe, K Webb, T Shuford, J Bowers, B Warren, AE Barnes, C Hall, IH
Citation: Bs. Burnham et al., Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cells, ARCH PHARM, 331(11), 1998, pp. 337-341
Risultati: 1-9 |